Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial - Concepedia

Concepedia

Publication | Closed Access

Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial

226

Citations

21

References

2020

Year

Peter J. Goadsby, David W. Dodick, Jessica Ailani, Joel M. Trugman, Michelle Finnegan, Kaifeng Lu, Armin Szegedi

The Lancet Neurology

Cluster HeadachePhase 2B/3MedicinePharmacologyPharmacotherapyNeurologyPlatelet AntagonistStrokeEpisodic Migraine

References

	Year	Citations

Page 1